Table 1.
Subject Participant Characteristics (n = 74)
| Control subjects (n = 49) | Patients with CMV IRU (n = 25) | P values | |||
| Characteristic | Mean | Mean | |||
| Number | Percent | Number | Percent | ||
| Age at index visita | Mean: 45.9 | Mean: 41.5 | 0.15 | ||
| <40 years | 10 | 20.4 | 9 | 36.0 | |
| 40–43.99 years | 10 | 20.4 | 8 | 32.0 | |
| 44–48.99 years | 14 | 28.6 | 5 | 20.0 | |
| ≥49 years | 15 | 30.6 | 3 | 12.0 | |
| Race/ethnicity | 0.49 | ||||
| White | 25 | 51.0 | 10 | 40.0 | |
| Black | 13 | 26.5 | 9 | 36.0 | |
| Hispanic | 10 | 20.4 | 5 | 20.0 | |
| American Indian | 0 | 0 | 1 | 4.0 | |
| Other | 1 | 2.0 | 0 | 0 | |
| Sex | 0.19 | ||||
| Male | 43 | 87.8 | 19 | 76.0 | |
| Female | 6 | 12.2 | 6 | 24.0 | |
| Prior Cidofovir prescription | |||||
| Yes | 0 | 0 | 5 | 20.0 | |
| No | 0 | 0 | 12 | 48.0 | |
| Unknown | 49 | 100 | 8 | 32.0 | |
| CD4 cell count,acells/μL | Mean: 412 | Mean: 410 | 0.86 | ||
| <250 | 12 | 24.5 | 7 | 28.0 | |
| 250–355 | 11 | 22.4 | 7 | 28.0 | |
| 356–502 | 14 | 28.6 | 5 | 20.0 | |
| >502 | 12 | 24.5 | 6 | 24.0 | |
| CD4 cell count, nadir cells/μL | Mean: 47 | Mean: 18 | 0.33 | ||
| Viral load,a logcopies/mL | Mean: 2.6 | Mean: 2.8 | 0.52 | ||
| <1.7 | 19 | 38.8 | 6 | 24.0 | |
| 1.7–2.699 | 14 | 28.6 | 10 | 40.0 | |
| 2.7–3.3 | 3 | 6.1 | 1 | 4.0 | |
| >3.3 | 10 | 20.4 | 7 | 28.0 | |
a Measured at the index visit.